Related Experiment Video
Updated: Sep 26, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Implementing universal vaccination programmes: USA
1Global Programme for Vaccines, Division of Communicable Diseases, WHO, Geneva, Switzerland.
Insights
All US infants receive the hepatitis B vaccine (HBV) as part of routine immunizations, offering at least 10 years of protection without needing booster shots or pre-vaccination screening.
Area of Science:
- Public Health
- Immunology
- Virology
Background:
- The United States mandates hepatitis B virus (HBV) vaccination for all infants.
- HBV vaccine integration into routine childhood schedules avoids extra healthcare visits.
- Current policy does not recommend booster doses due to sustained protection for at least 10 years.
Purpose of the Study:
- To summarize the current US policy on hepatitis B virus (HBV) vaccination for infants.
- To highlight the integration of HBV vaccination into routine childhood immunization schedules.
- To outline the approach to screening and immunization for HBV in pregnant women and newborns.
Main Methods:
- Review of current US vaccination policies for hepatitis B virus (HBV).
- Analysis of the rationale for not recommending booster doses.
- Description of screening protocols for pregnant women and immunization of infants born to HBsAg-positive mothers.
Main Results:
- Universal infant vaccination against HBV is standard practice in the USA.
- The HBV vaccine is effectively integrated into routine childhood immunization schedules.
- Screening of all pregnant women for HBsAg and immunizing infants of positive mothers continues.
Conclusions:
- The current US HBV vaccination policy ensures broad infant coverage.
- The established vaccination schedule is efficient, requiring no additional visits.
- Targeted screening and immunization strategies are maintained for high-risk infants.
Abstract:
In the USA, the policy is that all infants receive vaccine against hepatitis B virus (HBV). It is considered that HBV vaccine can be readily integrated into the routine childhood immunization schedule without additional visits. Booster doses of vaccine are not currently recommended because protection lasts for at least 10 years after vaccination. As with the other universal vaccination programmes, pre- or post-vaccination screening is not undertaken. Screening of all pregnant women for HBV surface antigen (HBsAg) and immunization of all infants of HBsAg-positive mothers has been continued.
Related Concept Videos
Vaccinations
Preventive Healthcare Services
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines
Smallpox
Poliomyelitis

